Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Topical tretinoin 0.025% cream is an effective treatment for Eruptive Vellus Hair Cysts in children.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Resveratrol activates the Nrf2 pathway in human skin, significantly increasing the production and distribution of the antioxidant glutathione.

The rash resolved after stopping ponatinib.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

A woman got a serious eye infection after a hair loss treatment due to improper procedure.

Ruxolitinib cream may help treat severe hair loss in children.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

A new gene mutation linked to KID syndrome was found, expanding genetic knowledge.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Cuscuta reflexa has potential medicinal benefits but needs more research for clinical use.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Eruptive vellus hair cysts are rare, benign skin lesions that are hard to treat.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Retinol with polylysine cleared scalp skin growths in 21 days without side effects.

Eruptive vellus hair cysts likely originate from the infrainfundibulum and sebaceous duct.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.